Daniel Ni

Daniel Ni inquired about the proportions of Voquezna prescriptions filled through LinkRx versus the new GoodRx offering, and the economics of these channels compared to traditional dispensaries.

Answer

Steven Basta, President and CEO, explained that GoodRx, launched in November, is currently a small percentage of overall numbers, offering copay support and a $199 cash pay option. He clarified that over half of total prescriptions go through the BlinkRx network, which routes them as covered or cash pay, with about 36% of total prescriptions being BlinkRx-dispensed cash scripts.

Daniel Ni from Goldman Sachs inquired about the proportions of prescriptions filled through BlinkRx versus the new GoodRx offering, and the economics of these channels compared to traditional dispensaries.

Answer

Steven Basta, President and CEO, explained that GoodRx, launched in November, offers a cash pay option at $199, but its numbers are currently small. He clarified that over half of total prescriptions go through the BlinkRx network, which routes them as covered scripts (appearing in IQVIA) or cash pay scripts (36% of total prescriptions).